Padsevonil
- Generic Name
- Padsevonil
- Drug Type
- Small Molecule
- Chemical Formula
- C14H14ClF5N4O2S
- CAS Number
- 1294000-61-5
- Unique Ingredient Identifier
- 0R1HN52K0N
- Background
Padsevonil is under investigation in clinical trial NCT03695094 (A Study in Participants With Epilepsy, to Evaluate the Pharmacokinetics, Safety and Tolerability of Oxcarbazepine on Padsevonil).
Study to Test the Efficacy and Safety of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adults With Drug-resistant Epilepsy
- Conditions
- Focal-Onset SeizuresDrug-resistant Epilepsy
- Interventions
- Other: Placebo
- First Posted Date
- 2017-12-14
- Last Posted Date
- 2023-12-19
- Lead Sponsor
- UCB Biopharma S.P.R.L.
- Target Recruit Count
- 411
- Registration Number
- NCT03373383
- Locations
- ๐บ๐ธ
Ep0091 830, Dallas, Texas, United States
๐บ๐ธEp0091 801, San Francisco, California, United States
๐บ๐ธEp0091 823, Orlando, Florida, United States
Study to Test the Safety and Efficacy of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adult Subjects With Drug-resistant Epilepsy
- First Posted Date
- 2017-12-12
- Last Posted Date
- 2021-12-29
- Lead Sponsor
- UCB Biopharma SRL
- Target Recruit Count
- 406
- Registration Number
- NCT03370120
- Locations
- ๐บ๐ธ
Ep0093 645, Golden Valley, Minnesota, United States
๐บ๐ธEp0093 806, Hackensack, New Jersey, United States
๐บ๐ธEp0093 802, Philadelphia, Pennsylvania, United States
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of UCB0942 in Healthy Japanese and Caucasian Subjects
- Conditions
- Healthy Japanese and Caucasian Subjects
- Interventions
- Other: Placebo
- First Posted Date
- 2017-05-30
- Last Posted Date
- 2017-08-22
- Lead Sponsor
- UCB Biopharma S.P.R.L.
- Target Recruit Count
- 48
- Registration Number
- NCT03168984
- Locations
- ๐ฌ๐ง
Up0039 001, London, United Kingdom
An Open-label Extension Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal Epilepsy
- First Posted Date
- 2015-12-09
- Last Posted Date
- 2022-03-09
- Lead Sponsor
- UCB Biopharma SRL
- Target Recruit Count
- 42
- Registration Number
- NCT02625090
- Locations
- ๐ง๐ช
Ep0073 103, Brussels, Belgium
๐ง๐ฌEp0073 201, Sofia, Bulgaria
๐ช๐ธEp0073 501, Sevilla, Spain
A Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal Epilepsy
- Conditions
- Highly Drug-resistant Focal Epilepsy
- Interventions
- Drug: Placebo
- First Posted Date
- 2015-07-13
- Last Posted Date
- 2019-02-05
- Lead Sponsor
- UCB Biopharma S.P.R.L.
- Target Recruit Count
- 55
- Registration Number
- NCT02495844
- Locations
- ๐ง๐ช
Ep0069 101, Gent, Belgium
๐ง๐ชEp0069 102, Leuven, Belgium
๐ฉ๐ชEp0069 402, Bielefeld, Germany
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.